A PVDF receiver for ultrasound monitoring of transcranial focused ultrasound therapy.

Department of Imaging Research, Sunnybrook Health Sciences Centre, Toronto, ON M4N3M5, Canada.
IEEE transactions on bio-medical engineering (Impact Factor: 2.23). 09/2010; 57(9):2286-94. DOI: 10.1109/TBME.2010.2050483
Source: PubMed

ABSTRACT Focused ultrasound (FUS) shows great promise for use in the area of transcranial therapy. Currently dependent on MRI for monitoring, transcranial FUS would benefit from a real-time technique to monitor acoustic emissions during therapy. A polyvinylidene fluoride receiver with an active area of 17.8 mm (2) and a film thickness of 110 mum was constructed. A compact preamplifier was designed to fit within the receiver to improve the receiver SNR and allow the long transmission line needed to remove the receiver electronics outside of the MRI room. The receiver was compared with a 0.5 mm commercial needle hydrophone and focused and unfocused piezoceramics. The receiver was found to have a higher sensitivity than the needle hydrophone, a more wideband response than the piezoceramic, and sufficient threshold for detection of microbubble emissions. Sonication of microbubbles directly and through a fragment of human skull demonstrated the ability of the receiver to detect harmonic bubble emissions, and showed potential for use in a larger scale array. Monitoring of disruption of the blood-brain barrier in rats showed functionality in vivo and the ability to detect subharmonic, harmonic, and wideband emissions during therapy. The receiver shows potential for monitoring acoustic emissions during treatments and providing additional parameters to assist treatment planning. Future work will focus on developing a multi-element array for transcranial treatment monitoring.

  • [Show abstract] [Hide abstract]
    ABSTRACT: A novel integrated high-voltage linear power amplifier for medical ultrasonic transmitter applications is presented in this brief. The amplifier employs a current-feedback technique with two cascading push–pull class-AB buffers. It overcomes the gain–bandwidth product limitation of a conventional voltage-feedback amplifier, capable of generating high output signal swing with a wide closed-loop bandwidth. In addition, a dynamic current biasing topology is integrated on-chip using a voltage-controlled current source and a 7-bit digital-to-analog converter (DAC). To further improve the signal linearity of the amplifier output, a digital predistortion (DPD) technique is applied by using a DAC, an analog-to-digital converter, and a digital field-programmable gate array. The presented amplifier was fabricated using a 1- $muhbox{m}$ 200-V CMOS process. The measurement results show that this integrated linear power amplifier is capable of driving a load of a 100- $Omega$ resistor in parallel with a 300-pF capacitor while achieving a signal swing up to 180 $V_{rm pp}$ with a second-order harmonic distortion as low as $-$50 dB. Measurement results also show that the amplifier achieves a maximum slew rate of 4 V/ns and a power efficiency of 30%. As a result, this power amplifier is expected to greatly improve medical ultrasound image quality.
    Circuits and Systems II: Express Briefs, IEEE Transactions on 06/2014; 61(6):373-377. DOI:10.1109/TCSII.2014.2305213 · 1.19 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The blood-brain barrier (BBB) can be transiently and locally opened by focused ultrasound (FUS) in the presence of microbubbles (MBs). Various imaging modalities and contrast agents have been used to monitor this process. Unfortunately, direct ultrasound imaging of BBB opening with MBs as contrast agent is not feasible, due to the inability of MBs to penetrate brain parenchyma. However, FUS-induced BBB opening is accompanied by changes in blood flow and perfusion, suggesting the possibility of perfusion-based ultrasound imaging. Here we evaluated the use of MB destruction-replenishment, which was originally developed for analysis of ultrasound perfusion kinetics, for verifying and quantifying FUS-induced BBB opening. MBs were intravenously injected and the BBB was disrupted by 2 MHz FUS with burst-tone exposure at 0.5-0.7 MPa. A perfusion kinetic map was estimated by MB destruction-replenishment time-intensity curve analysis. Our results showed that the scale and distribution of FUS-induced BBB opening could be determined at high resolution by ultrasound perfusion kinetic analysis. The accuracy and sensitivity of this approach was validated by dynamic contrast-enhanced MRI. Our successful demonstration of ultrasound imaging to monitor FUS-induced BBB opening provides a new approach to assess FUS-dependent brain drug delivery, with the benefit of high temporal resolution and convenient integration with the FUS device.
    Theranostics 01/2014; 4(10):1014-1025. DOI:10.7150/thno.9575 · 7.83 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: We established and tested an unconstrained sleep apnea monitoring method using a polyvinylidene (PVDF) film-based sensor for continuous and accurate monitoring of apneic events occurred during sleep. Twenty-six sleep apnea patients and six normal subjects participated in this study. Subjects’ respiratory signals were measured using the PVDF-based sensor during polysomnography. The PVDF sensor comprised a 4 × 1 array, and a thin silicon pad was placed over the sensor to prevent damage. Total thickness of the merged system was approximately 1.1 mm which was thin enough to prevent the subject from being consciously aware of its presence. It was designed to be placed under subjects’ backs and installed between a bed cover and mattress. The proposed method was based on the standard deviation of the PVDF signals, and it was applied to a test set for detecting apneic events. The method's performance was assessed by comparing the results with a sleep physician's manual scoring. The correlation coefficient for the apnea-hypopnea index (AHI) values between the methods was 0.94 $(p$ < 0.001). The areas under the receiver operating curves at three AHI threshold levels (>5, >15, and >20) for sleep apnea diagnosis were 0.98, 0.99, and 0.98, respectively. For min-by-min apnea detection, the method classified sleep apnea with an average sensitivity of 72.9%, specificity of 90.6%, accuracy of 85.5%, and kappa statistic of 0.60. The developed system and method can be applied to sleep apnea detection in home or ambulatory monitoring.
    IEEE Transactions on Biomedical Engineering 07/2014; 61(7):2125-2134. DOI:10.1109/TBME.2014.2314452 · 2.23 Impact Factor


Available from